NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from ...
Nasdaq3d
NeuroOne Medical Technologies CEO Discusses Epilepsy Treatment Advances and OneRF® Ablation System on Today’s Marketplace
NeuroOne Medical Technologies Corporation announced that CEO Dave Rosa participated in an interview on Today’s Marketplace, discussing advancements in epilepsy treatment alongside Dr. Jessica ...
NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
Submission for New Intended Use That Leverages Company’s Patented OneRF® Technology Platform Expected in May 2025 EDEN PRAIRIE, Minn., March 11, ...
NeuroOne accelerates timeline of submission for OneRF trigeminal nerve ablation
Technologies accelerated the anticipated timeline of its 510(k) submission to the FDA for trigeminal nerve ablation to ...
MassDevice10d
NeuroOne accelerates FDA submission timeline for nerve ablation tech
NeuroOne announced today that it accelerated the anticipated timeline of the FDA submission for its nerve ablation tech.
Morningstar3d
NeuroOne CEO Joins Today’s Marketplace To Discuss The Latest Treatments for Epilepsy
NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Today's Marketplace (TMP) is proud to announce a featured interview with NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) CEO Dave Rosa and ...
Yahoo Finance16d
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
NeuroOne CEO Dave Rosa will host a virtual corporate presentation at 9:20 a.m. eastern time on Wednesday, March 19, 2025, followed by one-on-one meetings, which can be requested through ...
Morningstar3d
NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update
EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving ...
Nasdaq3d
NeuroOne CEO Discusses Breakthrough OneRF System For Epilepsy Treatment On Today's Marketplace
(RTTNews) - NeuroOne Medical Technologies Corporation (NMTC), on Tuesday that CEO Dave Rosa was featured on Today's Marketplace or TMP, discussing the latest advancements in epilepsy treatment ...
manilatimes4d
NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy
NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Today's Marketplace (TMP) is proud to announce a featured interview with NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) CEO Dave Rosa and Jessica ...
Mena FN11d
Neuroone® Accelerates Timeline Of 510(K) Submission To FDA For The Onerf® Trigeminal Nerve Ablation System To Treat Facial Pain
EDEN PRAIRIE, Minn., March 11, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical Technology company focused on improving ...
NeuroOne CEO Joins Today’s Marketplace To Discuss The Latest Treatments for Epilepsy
Today's Marketplace (TMP) is proud to announce a featured interview with NeuroOne Medical Technologies Corporation (NASDAQ: ...